Yasuhiro Takeuchi
Overview
Explore the profile of Yasuhiro Takeuchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
305
Citations
7015
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Namba T, Takeuchi Y, Banerjee M
Theor Popul Biol
. 2025 Mar;
PMID: 40086602
In the intricate network of ecological interactions, intraguild predation emerges as a fundamental community module incorporating omnivory. Classical equilibrium theory predicts the exclusion of the intraguild predator and prey at...
3.
4.
Soen S, Uemura Y, Tanaka S, Takeuchi Y, Endo N, Takada J, et al.
J Bone Miner Metab
. 2025 Feb;
PMID: 39966121
Introduction: Patient satisfaction with two teriparatide (TPTD) self-injection regimens [once-daily (1/D)-TPTD and twice-weekly (2/W)-TPTD] was compared in a randomized crossover study involving patients with osteoporosis at high fracture risk. Materials...
5.
Oguni K, Goshima Y, Tatsushima K, Hayashida M, Urakami S, Ito S, et al.
Intern Med
. 2025 Feb;
PMID: 39894501
A 16-year-old girl presented with a high fever that had persisted for more than 4 weeks. Computed tomography (CT) revealed a 4-cm mass in the left adrenal gland. Clinically, there...
6.
Takeuchi Y
J Bone Miner Metab
. 2025 Jan;
PMID: 39825110
Purpose: Several osteoanabolic agents have been developed to build new bone more efficiently than anti-resorptive drugs. Among them, romosozumab, an anti-sclerostin antibody, is a potent pharmacological tool to prevent fractures...
7.
Takeuchi Y, Tanaka S, Kuroda T, Hagino H, Mori S, Soen S
Osteoporos Int
. 2024 Sep;
35(12):2175-2182.
PMID: 39343826
Purpose: Incidence rate of morphometric vertebral fracture was lower under treatment with once-weekly teriparatide (TPTD) followed by alendronate (ALN) than under treatment with ALN throughout the study among elderly Japanese...
8.
Hasegawa M, Sakakibara Y, Takeuchi Y, Sugitani I, Ozono K, Castriota F, et al.
JBMR Plus
. 2024 Aug;
8(9):ziae100.
PMID: 39193114
Hypoparathyroidism is a rare endocrine disorder characterized by low serum calcium and elevated serum phosphorus levels. Patients who do not recover parathyroid function after surgeries or have nonsurgical causes involving...
9.
Takeuchi Y, Nakatsuka Y, Tanaka S, Kuroda T, Hagino H, Mori S, et al.
J Bone Miner Metab
. 2024 Aug;
42(6):675-680.
PMID: 39141119
Introduction: To identify predictors of discontinuing treatment with teriparatide (TPTD) and alendronate (ALN), data from a randomized, controlled trial (JOINT-05) involving postmenopausal Japanese women at high risk of fracture were...
10.
Couto P, Stibbs D, Rotondi M, Khalife R, Wolf D, Takeuchi Y, et al.
Cytotherapy
. 2024 Jul;
26(11):1429-1441.
PMID: 38970611
The biological properties of human mesenchymal stromal cells (hMSCs) have been explored in over a thousand clinical trials in the last decade. Although hMSCs can be isolated from multiple sources,...